Dr. Robert Thomas Wendel, MD

Dr. Wendel practices at Retinal Consultants Medical Group, Inc in Folsom, California.

Dr. Wendel's NPI, 1235234634, was assigned on September 13, 2006. Dr. Wendel graduated from University Of Michigan Medical School in 1979. Dr. Wendel's California license number on file is G043291.

Dr. Wendel's primary practice is Retinal Consultants Medical Group, Inc, at 2330 E Bidwell St, Folsom, CA 95630 in Sacramento County. The practice phone is (916) 596-2027.

Dr. Wendel's primary practice is Retinal Consultants Medical Group, Inc in Folsom, California. Dmand AI also links Dr. Wendel to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wendel practices. Vendor and product names are available with a free account.

Retina specialist is Dr. Wendel's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Wendel is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Wendel's licenses on file in 2 states: California and Nevada.

Dmand AI lists age-related macular degeneration, cataract, dry eye, eyelid inflammation, glaucoma, inflammation of iris, laser destruction of retinal or choroid lesions and retinal detachment among the conditions Dr. Wendel treats.

CMS data shows 58,282 Medicare services from Dr. Wendel across 17 procedure codes in 2024, for 1,104 Medicare patients. Medicare paid $4,041,261 for them. Every service was in an office.

CMS counts 1,104 Medicare patients who saw Dr. Wendel in 2024. The largest group is 75 to 84, with 456 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wendel's median patient age at 72, with 52% women.

In 2024, Dr. Wendel wrote 242 Medicare Part D claims for 88 patients. 67% of them were for generic drugs. CMS names the drug for 193 of them, across 5 drugs with 11 or more claims each, at $4,876 in total drug cost. In 2023, CMS named 290 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Wendel for performance year 2024, reported as part of a group. Dr. Wendel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Wendel, published from 2013 to 2021. The most frequent topics are Visual Acuity, Fluorescein Angiography and Fundus Oculi. Dr. Wendel has published most often in Ophthalmology. Dr. Wendel's most frequent co-authors are Dante J. Pieramici, MD, Adrian Chichuen Au, MD and Robert Logan Avery, MD.

CMS Open Payments shows 136 general payments to Dr. Wendel from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 75% of the total. Genentech, Inc. paid the most, $1,648.

Dmand AI lists 4 awards for Dr. Wendel.

Dr. Wendel graduated from University Of Michigan Medical School in 1979. Dr. Wendel is a member of AAO.

Dr. Wendel is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.